Free Trial

McKesson (MCK) Competitors

McKesson logo
$662.71 +1.85 (+0.28%)
Closing price 03/25/2025 03:58 PM Eastern
Extended Trading
$670.24 +7.53 (+1.14%)
As of 03/25/2025 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MCK vs. COR, CAH, HSIC, PDCO, OMI, HLF, NUS, COSM, HWH, and MEDS

Should you be buying McKesson stock or one of its competitors? The main competitors of McKesson include Cencora (COR), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Owens & Minor (OMI), Herbalife (HLF), Nu Skin Enterprises (NUS), Cosmos Health (COSM), HWH International (HWH), and TRxADE HEALTH (MEDS).

McKesson vs.

Cencora (NYSE:COR) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, community ranking, media sentiment and dividends.

McKesson received 226 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 74.27% of users gave McKesson an outperform vote while only 65.30% of users gave Cencora an outperform vote.

CompanyUnderperformOutperform
CencoraOutperform Votes
747
65.30%
Underperform Votes
397
34.70%
McKessonOutperform Votes
973
74.27%
Underperform Votes
337
25.73%

Cencora currently has a consensus price target of $280.20, suggesting a potential upside of 4.43%. McKesson has a consensus price target of $649.36, suggesting a potential downside of 2.01%. Given Cencora's higher probable upside, analysts clearly believe Cencora is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cencora
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.80
McKesson
0 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.93

McKesson has a net margin of 0.82% compared to Cencora's net margin of 0.46%. Cencora's return on equity of 328.62% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
Cencora0.46% 328.62% 4.23%
McKesson 0.82%-181.26%5.34%

97.5% of Cencora shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 10.8% of Cencora shares are held by insiders. Comparatively, 0.1% of McKesson shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.8%. McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.4%. Cencora pays out 31.3% of its earnings in the form of a dividend. McKesson pays out 13.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has increased its dividend for 15 consecutive years and McKesson has increased its dividend for 17 consecutive years.

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cencora$638.56M81.48$1.51B$7.0338.17
McKesson$344.58B0.24$3.00B$21.8430.34

Cencora has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Comparatively, McKesson has a beta of 0.52, suggesting that its share price is 48% less volatile than the S&P 500.

In the previous week, McKesson had 5 more articles in the media than Cencora. MarketBeat recorded 39 mentions for McKesson and 34 mentions for Cencora. Cencora's average media sentiment score of 1.55 beat McKesson's score of 1.49 indicating that Cencora is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cencora
30 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
McKesson
36 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

McKesson beats Cencora on 14 of the 22 factors compared between the two stocks.

Remove Ads
Get McKesson News Delivered to You Automatically

Sign up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MCK vs. The Competition

MetricMcKessonDrugs, proprietaries, & sundries IndustryMedical SectorNYSE Exchange
Market Cap$83.05B$20.49B$5.68B$19.75B
Dividend Yield0.43%1.23%4.55%3.75%
P/E Ratio30.3411.5724.5534.05
Price / Sales0.249.39396.2228.57
Price / Cash18.3812.9538.1617.54
Price / Book-30.7130.937.064.63
Net Income$3.00B$785.39M$3.19B$1.02B
7 Day Performance-0.21%0.92%0.18%0.14%
1 Month Performance6.11%-6.56%5.53%-1.17%
1 Year Performance23.62%-14.45%14.21%7.30%

McKesson Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MCK
McKesson
4.1759 of 5 stars
$662.71
+0.3%
$649.36
-2.0%
+24.4%$83.05B$344.58B30.3475,000Positive News
COR
Cencora
3.9942 of 5 stars
$267.60
+0.1%
$280.20
+4.7%
+10.8%$51.96B$638.56M38.1246,000Positive News
CAH
Cardinal Health
4.4794 of 5 stars
$133.17
+1.0%
$139.36
+4.6%
+19.6%$32.16B$222.28B24.8448,900Positive News
HSIC
Henry Schein
4.1601 of 5 stars
$70.63
+1.8%
$81.10
+14.8%
-4.8%$8.77B$12.67B29.0622,000
PDCO
Patterson Companies
3.5659 of 5 stars
$31.20
+0.1%
$26.57
-14.8%
+15.1%$2.76B$6.51B18.247,600Analyst Revision
OMI
Owens & Minor
4.6532 of 5 stars
$9.25
+2.7%
$13.75
+48.7%
-65.3%$712.91M$10.70B-14.2013,700
HLF
Herbalife
4.6468 of 5 stars
$8.18
-3.0%
$12.00
+46.8%
-11.4%$827.45M$4.99B3.289,200
NUS
Nu Skin Enterprises
2.7329 of 5 stars
$7.44
-3.5%
$6.88
-7.6%
-45.4%$369.69M$1.73B-2.523,700
COSM
Cosmos Health
1.2182 of 5 stars
$0.49
+1.2%
N/A-23.6%$11.70M$56.04M-0.21100
HWH
HWH International
N/A$1.47
-6.7%
N/A-70.1%$9.15MN/A0.00N/AGap Down
MEDS
TRxADE HEALTH
N/A$2.01
+18.9%
N/A-79.9%$2.83M$7.45M0.0050Gap Up
High Trading Volume
Remove Ads

Related Companies and Tools


This page (NYSE:MCK) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners